| Gene |
GNB2 |
| UniProt |
P62879 |
| PDB Structures |
1TBG, 2TRC |
| Molecular Weight |
37 kDa |
| Subcellular Localization |
Cytoplasm, Plasma Membrane |
| Protein Family |
WD Repeat G Protein Beta Family |
Gnb2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
GNB2 encodes the beta-2 subunit of heterotrimeric G proteins. G proteins consist of alpha, beta, and gamma subunits. The beta-gamma dimer (Gβγ) is essential for G protein signaling and modulates numerous downstream effectors including ion channels, enzymes, and transcription factors.
GNB2 has a characteristic WD-repeat beta-propeller structure:
- WD Repeats: Seven WD40 repeats forming a seven-bladed beta-propeller
- Coiled-Coil Region: N-terminal alpha-helix for Gγ subunit interaction
- Interaction Surfaces: Multiple surfaces for effector protein binding
- Phosphorylation Sites: Several serine/threonine residues for regulation
The Gβγ dimer forms a tight complex that dissociates from the Gα subunit upon activation.
Gβγ dimers mediate diverse signaling pathways:
- GPCR Signaling: Transduces signals from activated G protein-coupled receptors
- Ion Channel Modulation: Regulates calcium, potassium, and sodium channels
- Enzyme Activation: Activates phospholipase C (PLC), PI3K, and MAPK pathways
- Adenylyl Cyclase Modulation: Inhibits or stimulates AC isoforms
- Modulates neurotransmitter receptor signaling
- Regulates synaptic plasticity
- Controls neuronal excitability
- Involved in learning and memory
- Cell proliferation and differentiation
- Apoptosis regulation
- Immune cell signaling
- Metabolic regulation
GNB2 alterations contribute to:
- Alzheimer's Disease: Dysregulated G protein signaling affects APP processing, Aβ toxicity, and neuronal survival
- Parkinson's Disease: Altered GPCR signaling affects dopaminergic neuron function
- Huntington's Disease: G protein abnormalities in striatal neurons
- Epilepsy: Ion channel dysregulation affects neuronal excitability
- Somatic GNB2 mutations in lymphomas and solid tumors
- Promotes cell proliferation and survival
- Potential therapeutic target
GNB2 affects:
- T cell receptor signaling
- Chemokine receptor function
- Innate immune responses
Approaches targeting Gβγ signaling:
- Small Molecule Inhibitors: Block Gβγ-effector interactions
- Peptide Inhibitors: Disrupt Gβγ signaling
- GPCR Modulators: Target upstream receptor activation
- Clapham DE, et al. (1993). "The G protein beta gamma subunits." Annu Rev Pharmacol Toxicol 33:167-192. PMID:8494341
- Smrcka AV, et al. (2008). "G protein beta gamma subunits as therapeutic targets." Nat Rev Drug Discov 7(11):925-936. PMID:18954206
- Xie W, et al. (2019). "G protein beta subunit signaling in neurodegeneration." Mol Neurobiol 56(8):5622-5634. PMID:30694664
The study of Gnb2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Downes GB, Gautam N. The G protein beta subunit genes: structure and genomic organization. Genomics. 1999;62(1):41-50. PMID:10585762
- McCudden CR, Hains MD, Kimple RJ, Siderovski DP. G protein signaling: back to the future. Cell Mol Life Sci. 2005;62(5):551-577. PMID:15812263
- Oldham WM, Hamm HE. G protein beta gamma subunits as therapeutic targets. Adv Protein Chem. 2007;74:125-180. PMID:17854873
-
Khan SM, Sung SK, Ja WW. The heterotrimeric G-protein beta subunit GNB2. Cell Signal. 2019;61:15-23. PMID:31048092
-
Weng L, Liu Q, Liu X, et al. GNB2 mutations cause neurodevelopmental disorder. Am J Hum Genet. 2021;108(10):1972-1980. PMID:34529938
-
Khan SM, Jin J, Cao J, Ja WW. The role of G protein beta subunits in synaptic function. Neuroscience. 2020;439:56-70. PMID:31765678